Advancing the Frontier of Immunotherapy

The full potential of the human immune system is yet to be unlocked. Prophylactic vaccines have been among the greatest achievements in human healthcare, demonstrating the power of natural immune responses when focused on the right targets. The next major advance in healthcare is upon us, as scientists expose chronic infections and cancers to the immune responses that can defeat them. Vedantra builds upon these advances, using the body’s natural immune responses against defined targets to create effective, durable, and safe therapies.

Collaborate with us

The people behind the science

Our scientists, partners, board members, and advisors include the leading minds in advancing immunotherapy.

Join us

William Koster, PhD

Executive chairman

Satish Jindal, PhD

Co-founder and Director

Steven Deitcher, MD

Director

Isaac Kohlberg, MBA

Director

Darrell Irvine, PhD

Founder and Scientific Consultant

Mark Carthy, MBA

Business Advisor to Board

George Siber, MD

Consultant

Adrienne Li

Senior Scientist

Jack Eby

Senior Scientist

Peter DeMuth

Senior Scientist